Search

Your search keyword '"Halioua, B"' showing total 465 results
Start Over Author "Halioua, B"
465 results on '"Halioua, B"'

2. Influence of Skin Subjective Symptoms on Sleep Quality in Patients with Cutaneous Disorders: A Study of 2871 Subjects

Author

Halioua B, Misery L, Seite S, Delvigne V, Chelli C, Taieb J, and Taieb C

Subjects
unpleasant sensations, sleep quality, cutaneous disorders, Dermatology, RL1-803
Abstract

Bruno Halioua,1 Laurent Misery,2,3 Sophie Seite,4 Veronique Delvigne,4 Clara Chelli,5 Jonathan Taieb,6 Charles Taieb7,8 1Dermatologue, Paris, France; 2Univ Brest, LIEN, F-29200, Brest, France; 3Department of Dermatologie, University Hospital of Brest, Brest, France; 4La Roche-Posay Laboratoire Dermatologique, Levallois-Perret, France; 5Department of Dermatology-Venereology, Robert-Debré Hospital, Reims, France; 6APHP, Hôtel Dieu, Centre du Sommeil et de la Vigilance, Paris, France; 7European Market Maintenance, Assessment, Patients Priority Department, Fontenay-sous-Bois, France; 8Hôpital Necker Enfants Malades, Paris, FranceCorrespondence: Bruno HaliouaDermatologue, 56 Boulevard Saint-Marcel, Paris, 75005, FranceEmail haliouab@yahoo.frIntroduction: Previous studies showed more sleep disturbance (SD) in patients with cutaneous disorders (CD). During CD, unpleasant subjective symptoms [USS], such as itch, pain and others (tingling, burning, or tightness) have a negative influence on sleep quality. This study aims to evaluate the prevalence of SD in CD patients and to identify the influence of itch, pain and other unpleasant sensations on SD.Materials and Methods: An international, anonymized real-life survey was conducted with individuals [18− 75 years], with physician-confirmed CD, or without CD. The 25 items covered sociodemographic characteristics, feeling of overall sleep quality and skin unpleasant sensations. Severity of SD and unpleasant sensations were assessed using a 10-cm Visual Analogue Scale (VAS).Results: From 3834 analyzed questionnaires, 2871 (67.3%) were in the CD group and 863 (32.7%) in the control group. Patients with CD had significantly more SD (71.2% vs 32.7% in the control group, p< 0.0001). CD patients without any reported unpleasant sensation were at higher risk for SD than control subjects (OR 1,362 [95% CI 1.975– 2.405] p=0.0013). SS were highly associated with SD (OR 1.641 [95% CI 1.393– 1.933] p< 0.0001). Pruritus, pain and intermediate sensations were significant predictors of SD, with odds ratios of 1.670, 1.625 and 1.326, respectively. VAS sleep scores were strongly associated with pruritus (r: 0.25, p< 0.0001) and pain (r: 0.25 p< 0.0001) severity ratings.Discussion: SD is a common problem for patients with CD. Patients with subjective symptoms suffer more from SD, suggesting that they are aggravating factors, but are likely not the only reason for SD in CD patients. We found that during CD, intermediate sensations also contribute to SD. Despite some limitations and the potential bias due to the study design, our results confirm for the first time on an international level the influence of subjective symptoms on sleep quality in patients with CD.Keywords: unpleasant sensations, sleep quality, cutaneous disorders

Published
2021

3. A novel calcipotriol and betamethasone dipropionate (CAL/BDP) PAD‐cream demonstrates greater improvements in daily activities and personal relationships than CAL/BDP gel/TS: a post‐hoc analysis of DLQI outcomes from two phase 3 placebo‐controlled randomized clinical trials in mild‐to‐moderate psoriasis

Author

Halioua, B., primary, Caillet, G., additional, Taieb, C., additional, Bewley, A., additional, Snel‐Prentø, A., additional, Praestegaard, M., additional, Armstrong, A., additional, and Pinter, A., additional

Published
2023
Full Text
View/download PDF

8. A novel calcipotriol and betamethasone dipropionate (CAL/BDP) PAD‐cream demonstrates greater improvements in daily activities and personal relationships than CAL/BDP gel/TS: A post‐hoc analysis of DLQI outcomes from two phase 3 placebo‐controlled randomized clinical trials in mild‐to‐moderate psoriasis

Author

Halioua, B., Caillet, G., Taieb, C., Bewley, A., Snel‐Prentø, A., Praestegaard, M., Armstrong, A., and Pinter, A.

Abstract

A post-hoc analysis of two phase 3 trials has shown that a novel calcipotriol and betamethasone dipropionate (CAL/BDP) PAD-cream offers greater improvements in daily activities and personal relationships compared to CAL/BDP gel/topical suspension (TS) for the treatment of psoriasis. The CAL/BDP PAD-cream, developed using Poly-Aphron Dispersion (PAD) Technology, is a non-greasy and easily spreadable cream that quickly absorbs into the skin. The analysis found that CAL/BDP PAD-cream significantly improved the impact of psoriasis on patients' daily activities, personal relationships, clothing choice, difficulties in doing sports, and sexual difficulties. These results highlight the importance of considering patients' perspectives in treatment decisions to achieve better outcomes. [Extracted from the article]

Published
2024
Full Text
View/download PDF

16. Impact de la dermatite atopique sur les conjoints des patients

Author

Misery, L., primary, Seneschal, J., additional, Corgibet, F., additional, Halioua, B., additional, Marquie, A., additional, Merhand, S., additional, Le Fur, G., additional, Bergqvist, C., additional, Taieb, C., additional, Staumont-Sallé, D., additional, Ezzedine, K., additional, and Richard, M.A., additional

Published
2022
Full Text
View/download PDF

19. Sexualité et désir de parentalité : le fardeau invisible de l’hidradénite suppurée dans une étude nationale française

Author

Fite, C., Taieb, C., Delage-Toriel, M., Nassif, A., Skayem, C., Cassius, C., Benhayoun, Y., Bru, M.F., Moulin, M., Le Floc’h, C., Kerob, D., Caillet, G., Demessant, A.L., Joubert, J.M., Halioua, B., Zimmermann, C., Pommaret, E., Nicol, I., Cogrel, O., and Richard, M.A.

Abstract

L’hidradénite suppurée (HS) altère considérablement la vie quotidienne des patients, entraînant une stigmatisation sociale et affectant leur vie professionnelle. Cet impact est principalement dû à la localisation anatomique des lésions, à leur nature ainsi qu’à la chronicité et à l’imprévisibilité des poussées. Peu de recherches ont évalué les conséquences de l’HS sur la sexualité et le désir de parentalité des femmes atteintes.

Published
2024
Full Text
View/download PDF

44. CHEMIN : évaluation des pratiques dans la prise en charge de l’eczéma chronique des mains, une enquête nationale française

Author

Leleu, C., Crépy, M.N., Bernier, C., Halioua, B., Tauber, M., and Soria, A.

Abstract

En l’absence de recommandations françaises, les professionnels de santé s’appuient souvent sur leur expérience personnelle pour prendre en charge l’eczéma chronique des mains (ECM). Cette enquête visait à identifier les pratiques actuelles en France dans l’ECM, en comparaison aux recommandations de la Société européenne de dermatite de contact (ESCD).

Published
2024
Full Text
View/download PDF

46. Prévention des MST

Author

Derancourt, C.H., Vernay-Vaisse, C.H., Timsit, F.-J., Verraes-Derancourt, S., Passeron, A., and Halioua, B.

Published
2006
Full Text
View/download PDF

48. Herpès génital

Author

Le Goff, J., primary, Halioua, B., additional, Milpied, B., additional, and Chosidow, O., additional

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results